Provided the critical roles of MYC and TGF-β signaling in the advanced prostate cancer subtypes, our results highly suggest curcumin as a novel anti-cancer supplementary treatment option for non-indolent prostate cancer resistant to hormone and chemical therapies. This evidence concerns the gene TGFB1 and Familial prostate cancer.